BioCryst
Executive Summary
Founder Charles Bugg, PhD, reassumes position of CEO of the Birmingham, Ala. structure-based drug design company, replacing Frederick Dechow, PhD, who will remain at BioCryst as president and COO. Bugg, who served as the first CEO of the firm in 1987-88, has been serving as director of the University of Alabama-Birmingham's Center for Macromolecular Crystallography.